Work

Cholangiocarcinoma Targeted Therapies

Year: 2024

Type: review

Source: American Journal Of Pathology

DOI: 10.1016/j.ajpath.2024.11.005

Authors: Haley Ellis, Chiara Braconi, Juan W. Valle, Nabeel Bardeesy

Institutions: Harvard University, Massachusetts General Hospital, Beatson West of Scotland Cancer Centre, University of Glasgow, University of Manchester, Cholangiocarcinoma Foundation

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, National Institutes of Health, National Cancer Institute

Awards: Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer, Understanding Mechanisms of Resistance to Anti-angiogenic Treatments, G5726703104, G7412833063, Functions of mutant IDH in cholangiocarcinoma

OpenAlex ID: W4405586840

FWCI: 2.868

Cites: 119

Cited by: 26

Related to: 10